glutathione s transferase alverine RCSB PDB Glutathione S-transferase | Glutathione transferases;

Hu T, Schreiter FC, Bagchi RA, Tatman PD, Hannink M, McKinsey TA

The Glutathione industry is valued at US$ 324.6 million in 2025, and is estimated to hit the US$ 585.8 million mark by the year 2032, reflecting an annual growth rate of 8.8%

The benefits of maintaining healthy levels are numerous, including acute or chronic illnesses such as: Alzheimers disease Cancer Chronic fatigue syndrome Cystic fibrosis Multiple sclerosis Repeated exposure to toxins & heavy metals Inflammatory diseases such as arthritis Cardiovascular disease COPD, asthma, or any chronic breathing problems Chronic stress Anxiety Aging Neurological diseases Viral hepatitis or Cirrhosis Autism

Restorative sleep supports antioxidant defenses, including glutathione, while chronic sleep loss has been linked to lower glutathione activity

These shifts in the redox state can modulate key signaling pathways that govern cell fate, such as NOTCH (Neurogenic locus notch homolog protein)

This is the first study to identify HO-1 deficiency in humans, exhibiting an increased inflammatory response